17-47253855-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000212.3(ITGB3):​c.-7G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.029 in 1,219,630 control chromosomes in the GnomAD database, including 1,156 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 211 hom., cov: 32)
Exomes 𝑓: 0.029 ( 945 hom. )

Consequence

ITGB3
NM_000212.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.331

Publications

4 publications found
Variant links:
Genes affected
ITGB3 (HGNC:6156): (integrin subunit beta 3) The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]
ITGB3 Gene-Disease associations (from GenCC):
  • Glanzmann thrombasthenia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Glanzmann thrombasthenia 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • bleeding disorder, platelet-type, 24
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • platelet-type bleeding disorder 16
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant macrothrombocytopenia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Glanzmann's thrombasthenia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 17-47253855-G-C is Benign according to our data. Variant chr17-47253855-G-C is described in ClinVar as Benign. ClinVar VariationId is 255534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGB3NM_000212.3 linkc.-7G>C 5_prime_UTR_variant Exon 1 of 15 ENST00000559488.7 NP_000203.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGB3ENST00000559488.7 linkc.-7G>C 5_prime_UTR_variant Exon 1 of 15 1 NM_000212.3 ENSP00000452786.2
ITGB3ENST00000571680.1 linkc.-7G>C 5_prime_UTR_variant Exon 1 of 9 1 ENSP00000461626.1
ITGB3ENST00000696963.1 linkc.-7G>C 5_prime_UTR_variant Exon 1 of 14 ENSP00000513002.1
ENSG00000259753ENST00000560629.1 linkn.-43G>C upstream_gene_variant 2 ENSP00000456711.2

Frequencies

GnomAD3 genomes
AF:
0.0291
AC:
4414
AN:
151572
Hom.:
213
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00638
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0243
Gnomad ASJ
AF:
0.0358
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.100
Gnomad FIN
AF:
0.0273
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0243
Gnomad OTH
AF:
0.0326
GnomAD2 exomes
AF:
0.0345
AC:
78
AN:
2262
AF XY:
0.0322
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0217
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.500
Gnomad FIN exome
AF:
0.0278
Gnomad NFE exome
AF:
0.0200
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0290
AC:
30954
AN:
1067952
Hom.:
945
Cov.:
29
AF XY:
0.0292
AC XY:
14799
AN XY:
506386
show subpopulations
African (AFR)
AF:
0.00483
AC:
107
AN:
22166
American (AMR)
AF:
0.0182
AC:
143
AN:
7870
Ashkenazi Jewish (ASJ)
AF:
0.0302
AC:
406
AN:
13432
East Asian (EAS)
AF:
0.200
AC:
4998
AN:
25030
South Asian (SAS)
AF:
0.0891
AC:
1819
AN:
20412
European-Finnish (FIN)
AF:
0.0329
AC:
708
AN:
21526
Middle Eastern (MID)
AF:
0.0322
AC:
93
AN:
2886
European-Non Finnish (NFE)
AF:
0.0229
AC:
20915
AN:
912266
Other (OTH)
AF:
0.0417
AC:
1765
AN:
42364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1265
2530
3794
5059
6324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
976
1952
2928
3904
4880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0291
AC:
4411
AN:
151678
Hom.:
211
Cov.:
32
AF XY:
0.0318
AC XY:
2356
AN XY:
74152
show subpopulations
African (AFR)
AF:
0.00637
AC:
264
AN:
41468
American (AMR)
AF:
0.0242
AC:
368
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.0358
AC:
124
AN:
3464
East Asian (EAS)
AF:
0.226
AC:
1155
AN:
5102
South Asian (SAS)
AF:
0.101
AC:
487
AN:
4826
European-Finnish (FIN)
AF:
0.0273
AC:
285
AN:
10436
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.0244
AC:
1653
AN:
67838
Other (OTH)
AF:
0.0318
AC:
67
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
197
394
590
787
984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0237
Hom.:
9
Bravo
AF:
0.0282
Asia WGS
AF:
0.138
AC:
476
AN:
3444

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glanzmann thrombasthenia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
15
DANN
Benign
0.88
PhyloP100
0.33
PromoterAI
0.0054
Neutral
Mutation Taster
=297/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117052258; hg19: chr17-45331221; API